V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20022943 | 20009735 | 1.69 | 78.5 | Adjuvant (A) | 2012-07-27 | 2016-01-26 | FEC 100 + DOCETAXEL | N | N | 20080926 | FEC + DOCETAXEL |
| 20022944 | 20009736 | 1.7 | 80.4 | Adjuvant (A) | 2017-06-02 | 2017-06-23 | FEC 100 + DOCETAXEL | N | null | 20080930 | FEC + DOCETAXEL |
| 20022945 | 20009736 | 1.78 | 49 | Adjuvant (A) | 2013-12-08 | 2013-12-10 | FEC + DOCETAXEL | Y | N | 20080930 | FEC + DOCETAXEL |
| 20022946 | 20009737 | null | 96.5 | Adjuvant (A) | 2013-11-26 | 2013-12-04 | FEC + DOCETAXEL | 99 | null | 20080938 | FEC + DOCETAXEL |
| 20022947 | 20070574 | 1.74 | 70.5 | Adjuvant (A) | 2017-08-12 | 2017-08-14 | FEC 100 + DOCETAXEL | 02 | null | 20080942 | FEC + DOCETAXEL |
| 20022948 | 20009738 | 1.72 | 75.4 | Neo-adjuvant (N) | 2016-05-06 | 2016-05-06 | FEC + DOCETAXEL | 2 | N | 20080943 | FEC + DOCETAXEL |
| 20022949 | 20009738 | 1.69 | 94 | Curative (C) | 2014-09-14 | 2014-09-15 | FEC + DOCETAXEL | N | N | 20080943 | FEC + DOCETAXEL |
| 20022950 | 20009739 | 1.61 | 64.5 | Adjuvant (A) | 2014-09-19 | 2014-09-22 | FEC + DOCETAXEL | N | null | 20080950 | FEC + DOCETAXEL |
| 20022951 | 20009739 | 1.63 | 59 | Adjuvant (A) | 2013-09-23 | 2013-09-23 | FEC + DOCETAXEL | 2 | N | 20080950 | FEC + DOCETAXEL |
| 20022952 | 20009739 | 1.78 | 65.4 | Neo-adjuvant (N) | null | 2015-10-06 | FEC + DOCETAXEL | N | N | 20080950 | FEC + DOCETAXEL |
| 20022953 | 20009740 | 1.64 | 66 | Neo-adjuvant (N) | 2015-11-14 | 2015-11-15 | FEC 100 + DOCETAXEL | 02 | N | 20080963 | FEC + DOCETAXEL |
| 20022954 | 20009740 | null | 73.5 | Adjuvant (A) | 2014-10-01 | 2014-10-29 | FEC + DOCETAXEL | N | N | 20080963 | FEC + DOCETAXEL |
| 20022955 | 20009741 | 1.57 | 110 | Not known (9) | 2014-08-24 | 2014-09-06 | FEC + DOCETAXEL | 02 | N | 20080967 | FEC + DOCETAXEL |
| 20022956 | 20009742 | 1.58 | 92 | Disease modification (D) | 2017-03-04 | 2017-03-04 | FEC 100 + DOCETAXEL | 2 | N | 20080972 | FEC + DOCETAXEL |
| 20022957 | 20009743 | 1.66 | 57.4 | Adjuvant (A) | 2017-06-29 | 2017-07-14 | FEC 100 + DOCETAXEL | N | N | 20080977 | FEC + DOCETAXEL |
| 20022958 | 20009743 | 1.6 | 66 | Neo-adjuvant (N) | 2013-05-14 | 2013-05-25 | FEC 100 + DOCETAXEL | 02 | N | 20080977 | FEC + DOCETAXEL |
| 20022959 | 20009743 | 1.61 | 75.6 | Neo-adjuvant (N) | 2016-02-03 | 2016-02-20 | FEC + DOCETAXEL | N | N | 20080977 | FEC + DOCETAXEL |
| 20022960 | 20009743 | null | null | null | 2017-04-01 | 2017-04-01 | FEC + DOCETAXEL | N | null | 20080977 | FEC + DOCETAXEL |
| 20022961 | 20009744 | null | 63 | Adjuvant (A) | 2014-09-22 | 2014-10-14 | FEC + DOCETAXEL | 02 | N | 20080999 | FEC + DOCETAXEL |
| 20022962 | 20009744 | 1.6 | null | null | 2017-07-29 | 2017-08-05 | FEC + DOCETAXEL | N | N | 20080999 | FEC + DOCETAXEL |
| 20022963 | 20009744 | 1.66 | 93.5 | Not known (9) | 2015-09-25 | 2015-10-05 | FEC + DOCETAXEL | 2 | null | 20080999 | FEC + DOCETAXEL |
| 20022964 | 20009745 | 1.65 | 64 | Adjuvant (A) | 2013-07-02 | 2013-07-14 | FEC 100 + DOCETAXEL | N | N | 20081006 | FEC + DOCETAXEL |
| 20022965 | 20009746 | 1.67 | 64 | Adjuvant (A) | 2013-05-06 | 2013-05-09 | FEC + DOCETAXEL | 02 | N | 20081008 | FEC + DOCETAXEL |
| 20022966 | 20009746 | 1.51 | 79 | Curative (C) | 2015-07-06 | 2015-07-06 | FEC + DOCETAXEL | 02 | N | 20081008 | FEC + DOCETAXEL |
| 20022967 | 20009746 | 1.71 | 70 | Adjuvant (A) | 2016-10-15 | 2016-10-29 | FEC + DOCETAXEL | N | N | 20081008 | FEC + DOCETAXEL |
| 20022968 | 20009747 | 1.65 | 59 | Neo-adjuvant (N) | 2013-06-22 | 2013-06-22 | FEC + DOCETAXEL | 02 | N | 20081011 | FEC + DOCETAXEL |
| 20022969 | 20070581 | 1.64 | 66 | Adjuvant (A) | null | 2016-09-20 | FEC 100 + DOCETAXEL | null | null | 20081016 | FEC + DOCETAXEL |
| 20022970 | 20070581 | 1.61 | 86 | Adjuvant (A) | 2015-03-07 | 2015-03-14 | FEC 100 + DOCETAXEL | N | N | 20081016 | FEC + DOCETAXEL |
| 20022971 | 20070581 | null | 73.5 | Adjuvant (A) | 2014-08-23 | 2014-09-22 | FEC + DOCETAXEL | 2 | N | 20081016 | FEC + DOCETAXEL |
| 20022972 | 20070581 | 1.59 | null | null | 2014-11-30 | 2014-11-30 | FEC 100 + DOCETAXEL | N | N | 20081016 | FEC + DOCETAXEL |
| 20022973 | 20070581 | 1.74 | 65 | Adjuvant (A) | 2013-09-22 | 2013-10-08 | FEC + DOCETAXEL | 02 | N | 20081016 | FEC + DOCETAXEL |
| 20022974 | 20009748 | 1.64 | 54 | null | 2015-11-17 | 2015-12-06 | FEC + DOCETAXEL | N | N | 20081030 | FEC + DOCETAXEL |
| 20022975 | 20009749 | null | 49.6 | Adjuvant (A) | 2018-03-17 | 2018-03-31 | FEC + DOCETAXEL | 2 | N | 20081031 | FEC + DOCETAXEL |
| 20022976 | 20009749 | 1.64 | 55.9 | Adjuvant (A) | null | 2014-06-29 | FEC 100 + DOCETAXEL | null | N | 20081031 | FEC + DOCETAXEL |
| 20022977 | 20009750 | 1.68 | null | Neo-adjuvant (N) | 2016-07-13 | 2016-07-27 | FEC + DOCETAXEL | 99 | null | 20081035 | FEC + DOCETAXEL |
| 20022978 | 20009750 | 1.65 | 73 | Adjuvant (A) | 2016-10-30 | 2016-11-08 | FEC + DOCETAXEL | N | N | 20081035 | FEC + DOCETAXEL |
| 20022979 | 20009750 | 1.66 | 85 | Adjuvant (A) | 2018-03-23 | 2018-03-23 | FEC + DOCETAXEL | 02 | Y | 20081035 | FEC + DOCETAXEL |
| 20022980 | 20009751 | null | 81 | Adjuvant (A) | 2013-11-09 | 2013-11-14 | FEC + DOCETAXEL | N | null | 20081055 | FEC + DOCETAXEL |
| 20022981 | 20009751 | 1.66 | 54.5 | Adjuvant (A) | 2013-06-06 | 2013-06-20 | FEC + DOCETAXEL | N | N | 20081055 | FEC + DOCETAXEL |
| 20022982 | 20009751 | 1.7 | 65.6 | Neo-adjuvant (N) | 2014-03-22 | 2014-04-26 | FEC 100 + DOCETAXEL | N | N | 20081055 | FEC + DOCETAXEL |
| 20022983 | 20009751 | 1.7 | 85.4 | Curative (C) | 2017-09-09 | 2017-11-01 | FEC + DOCETAXEL | 02 | N | 20081055 | FEC + DOCETAXEL |
| 20022984 | 20009751 | 1.6 | 64.9 | Neo-adjuvant (N) | null | 2016-08-24 | FEC + DOCETAXEL | N | N | 20081055 | FEC + DOCETAXEL |
| 20022985 | 20009752 | 1.64 | 63.1 | Neo-adjuvant (N) | 2013-05-23 | 2013-05-24 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | Y | 20081085 | FEC + DOCETAXEL |
| 20022986 | 20009753 | 1.57 | 96 | Adjuvant (A) | 2014-11-06 | 2014-11-17 | FEC + DOCETAXEL | 2 | N | 20081093 | FEC + DOCETAXEL |
| 20022987 | 20009753 | 1.56 | 69 | Adjuvant (A) | 2013-10-23 | 2013-11-20 | FEC + DOCETAXEL | N | N | 20081093 | FEC + DOCETAXEL |
| 20022988 | 20108260 | 1.57 | 80.2 | Adjuvant (A) | 2016-06-24 | 2016-07-05 | FEC + DOCETAXEL | 02 | null | 20081097 | FEC + DOCETAXEL |
| 20022989 | 20009754 | 1.58 | 67.6 | Adjuvant (A) | 2017-10-11 | 2017-10-15 | FEC + DOCETAXEL | 2 | N | 20081101 | FEC + DOCETAXEL |
| 20022990 | 20070586 | 1.67 | 56.1 | Adjuvant (A) | 2013-03-27 | 2013-04-02 | FEC + DOCETAXEL | 02 | N | 20081103 | FEC + DOCETAXEL |
| 20022991 | 20108261 | 1.7 | 58.8 | Adjuvant (A) | 2017-12-11 | 2017-12-11 | FEC + DOCETAXEL | 2 | N | 20081106 | FEC + DOCETAXEL |
| 20022992 | 20108261 | null | null | Adjuvant (A) | 2014-06-11 | 2014-06-16 | FEC + DOCETAXEL | N | null | 20081106 | FEC + DOCETAXEL |